Enzyme blockade improves memory updating in older mice

Everyone has moments of forgetfulness from time to time, especially as we get older. But older adults don’t just have difficulty remembering new information.

Getting CRISPR treatments to patients remains a major challenge. Could lab-developed tests help?

CRISPR is no longer a promising but unproven technology — it is a reality. But for this powerful gene-editing tool to reach its full potential,

March 21, 2024

AbbVie bets $48M upfront for early-stage antibody targeting chronic inflammation

AbbVie is making good on its plans to search for new mechanisms of action, this time with French biotech OSE Immunotherapeutics for a monoclonal antibody

February 29, 2024

Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company – Medical Marijuana, Inc.

SAN DIEGO–(BUSINESS WIRE)–Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), announced today that its network marketing division, Kannaway, has completed an Asset Purchase Agreement with eXfuse, LLC,

August 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.